Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Encapsulated papillary carcinoma arising in ectopic breast tissue in the vulva: A case report and review of literature.
Journal: Gynecologic oncology reports
Published: December 09, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 04, 2025
Trends in estimated PARP inhibitor eligibility and benefit among US epithelial ovarian cancer patients.
Journal: Gynecologic oncology
Published: January 16, 2024
Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.
Journal: Gynecologic oncology reports
Published: April 03, 2022
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status.
Journal: Gynecologic oncology reports
Published: March 27, 2022
Surgical outcomes of adnexal masses classified by IOTA ultrasound simple rules.
Journal: Scientific reports
Published: February 21, 2022
Benign ovarian thecoma with markedly elevated serum inhibin B levels mimicking adult granulosa cell tumor.
Journal: Gynecologic oncology reports
Published: August 02, 2020
Uterine Cervical Sarcoma With a Novel RET-SPECC1L Fusion in an Adult: A Case Which Expands the Homology Between RET-rearranged and NTRK-rearranged Tumors.
Journal: The American journal of surgical pathology
Published: January 10, 2020
Implementation of a standardized voiding management protocol to reduce unnecessary re-catheterization - A quality improvement project.
Journal: Gynecologic oncology
Published: December 20, 2019
In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide.
Journal: Antimicrobial agents and chemotherapy
Published: March 20, 2013
A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo.
Journal: Investigative ophthalmology & visual science
Published: January 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026